Transplantation with human umbilical cord blood mononuclear cells (HUCBC) has demonstrated promising results in various disease states. While some of the positive results are credited to HUCBCs’ differentiation potential, the... When HUCBCs secrete growth factors and anti-inflammatory cytokines, they are thought to reduce inflammation and associated damage.
- Mechanism
- Curator reviewed
Mononuclear umbilical cord cells have the ability to secrete cytokines, growth factors, interleukins,and chemokines. As many of these factors can have anti-inflammatory, angiogenic, and neuroprotective effects, it is thought that the conditioned media may exert some therapeutic potential related to these effects.
- Also known as
- Umbilical Cord Blood Mononuclear Cells Conditioned Medium
- Code names
- Human umbilical cord blood mononuclear cell-conditioned medium
What you can answer from here — as of March 06, 2025
Which companies are running trials of Human umbilical cord blood mononuclear cell-conditioned medium, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account